Medical startup Osimis raises €2.3 million to accelerate its development

Based on the free and open-source Orthanc technology, Osimis’ Lify® solution simplifies the exchange and consultation of medical imaging studies. The platform is very ergonomic and appreciated by many experts.

Patrice Sapey, Director of the Saint-Catherine Cancer Institute in Avignon: “We found in Lify ® a certain flexibility, responsiveness and tool customization of the tool goes beyond the robustness of the system that had already been validated by our IT teams”.

“Expert in a niche global market, Osimis aims to strengthen its presence in Europe, North America and Asia. The Osimis team is the main contributor to the Orthanc open source project for medical imaging. Orthanc has been downloaded more than 230,000 times and is used in 192 countries. Lify® is Osimis’ proprietary platform that allows for a fast and ergonomic grip and deployment of Orthanc for the health industry: inter-hospital exchanges, dissemination to patients, integration with partners in artificial intelligence, etc.

For its third year, Osimis has doubled its sales to EUR 0.5 million and is currently active in 14 countries. Among its 60 clients and partners, 22 are hospitals.

Holder of a doctoral degree in computer science from the University of Liège and specialized in digital image processing, Sébastien Jodogne, Chief Scientific Officer (CSO), initiated the Orthanc project in 2011 in the department of medical physics of the University Hospital of Liège. He says: “As an initiator of the project in an academic setting thanks to the support of the University Hospital of Liège, I am delighted that we are thus opening a new page in the already long history of the free and open-source Orthanc ecosystem. The scientific and societal impact of Orthanc has been praised internationally and is part of a philosophy of openness and dissemination of knowledge.”

Frédéric Lambrechts, CEO, says: “This fundraising will enable us to accelerate the development and international expansion of the Lify ® platform. Our goal is to improve the clinical pathway and the patient’s life, across all dimensions of medical imaging. Technology and innovation are first and foremost tools that must be put to the service of the patient. Our approach to this effect is to bring algorithmic innovation closer to clinical practice in the context of medical imaging. We are looking for computer scientists and commercial medical technology to keep up with demand.”

Dr. PhD Erik Ranschaert, medical advisor and investor, states that “with Lify, Osimis brings an elegant solution that corresponds to the missing piece of the medical data puzzle. Data that is distributed throughout the hospital, can now be managed as a whole, therewith enabling to take the next step in personalized care.”

The company has just raised EUR 2.3 million from experts in medical technologies and formed an experienced Board of Directors (*): Marc Nolet (founder of Physiol, intraocular lenses), Trasis * (leader in radiopharmacy), Dr. PhD Erik Ranschaert (radiologist and expert in artificial intelligence), Jacques Galloy * (Gaudeto, digital imaging, chairman of the Board), Frédéric Lambrechts * (CEO) and specialized funds: W.IN.G * / SRIW, Noshaq / Spinventure * (Meusinvest group) and BeAngels.

On behalf of the new shareholders and W.IN.G, Damien Lourtie, General Manager, said: “We are pleased to once again confirm our confidence in Osimis as this investment is fully in line with the new strategy of the W.IN.G fund, which is to support the growth of companies active in the digital transition.”